Matches in Nanopublications for { ?s ?p "[These results suggest that p53 is an important down regulator of FAK and that loss of p53 function in breast cancer may contribute to the metastatic potential of estrogen-responsive tumors through uncontrolled FAK expression upon estrogens stimulation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP653765.RAAzMi0v-cjceAEWbusFFnhfqe7kwHxEBHn9EDGSCpj04130_assertion description "[These results suggest that p53 is an important down regulator of FAK and that loss of p53 function in breast cancer may contribute to the metastatic potential of estrogen-responsive tumors through uncontrolled FAK expression upon estrogens stimulation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP653765.RAAzMi0v-cjceAEWbusFFnhfqe7kwHxEBHn9EDGSCpj04130_provenance.
- NP659271.RAar7L9iImvmKIe00ERJ1o4mAFRcKL9ilY2m3DX__k0Og130_assertion description "[These results suggest that p53 is an important down regulator of FAK and that loss of p53 function in breast cancer may contribute to the metastatic potential of estrogen-responsive tumors through uncontrolled FAK expression upon estrogens stimulation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP659271.RAar7L9iImvmKIe00ERJ1o4mAFRcKL9ilY2m3DX__k0Og130_provenance.
- assertion description "[These results suggest that p53 is an important down regulator of FAK and that loss of p53 function in breast cancer may contribute to the metastatic potential of estrogen-responsive tumors through uncontrolled FAK expression upon estrogens stimulation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These results suggest that p53 is an important down regulator of FAK and that loss of p53 function in breast cancer may contribute to the metastatic potential of estrogen-responsive tumors through uncontrolled FAK expression upon estrogens stimulation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These results suggest that p53 is an important down regulator of FAK and that loss of p53 function in breast cancer may contribute to the metastatic potential of estrogen-responsive tumors through uncontrolled FAK expression upon estrogens stimulation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These results suggest that p53 is an important down regulator of FAK and that loss of p53 function in breast cancer may contribute to the metastatic potential of estrogen-responsive tumors through uncontrolled FAK expression upon estrogens stimulation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP851973.RAbK5XjM9fFlTtvoGynDFTFctWL-Uz1Ma4fbIB4n3zYec130_assertion description "[These results suggest that p53 is an important down regulator of FAK and that loss of p53 function in breast cancer may contribute to the metastatic potential of estrogen-responsive tumors through uncontrolled FAK expression upon estrogens stimulation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP851973.RAbK5XjM9fFlTtvoGynDFTFctWL-Uz1Ma4fbIB4n3zYec130_provenance.
- NP659384.RArcB5cwcmi9Ul_JNB7B2tXVmyOM1r3N-LvZ603nGWP-I130_assertion description "[These results suggest that p53 is an important down regulator of FAK and that loss of p53 function in breast cancer may contribute to the metastatic potential of estrogen-responsive tumors through uncontrolled FAK expression upon estrogens stimulation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP659384.RArcB5cwcmi9Ul_JNB7B2tXVmyOM1r3N-LvZ603nGWP-I130_provenance.
- NP851971.RAN-mp13IeBZ-bs-8eVhEKrDcd6MLavho0WnAuT7UZeGw130_assertion description "[These results suggest that p53 is an important down regulator of FAK and that loss of p53 function in breast cancer may contribute to the metastatic potential of estrogen-responsive tumors through uncontrolled FAK expression upon estrogens stimulation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP851971.RAN-mp13IeBZ-bs-8eVhEKrDcd6MLavho0WnAuT7UZeGw130_provenance.
- NP851972.RAOKSk9LzS70qm9Y0v0xI23a1NjYP7FbBBR33tB_cbjGQ130_assertion description "[These results suggest that p53 is an important down regulator of FAK and that loss of p53 function in breast cancer may contribute to the metastatic potential of estrogen-responsive tumors through uncontrolled FAK expression upon estrogens stimulation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP851972.RAOKSk9LzS70qm9Y0v0xI23a1NjYP7FbBBR33tB_cbjGQ130_provenance.
- NP851968.RA_aGAwT71r4sM4vMyhAOu_UPLzE6D9caKBLQ1bMHohTE130_assertion description "[These results suggest that p53 is an important down regulator of FAK and that loss of p53 function in breast cancer may contribute to the metastatic potential of estrogen-responsive tumors through uncontrolled FAK expression upon estrogens stimulation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP851968.RA_aGAwT71r4sM4vMyhAOu_UPLzE6D9caKBLQ1bMHohTE130_provenance.